Pear Therapeutics, Inc.
PEAR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75,491 | -$65,142 | -$97,023 | -$9,334 |
| Dep. & Amort. | $5,702 | $2,252 | $431 | $209 |
| Deferred Tax | $0 | $298 | $1,793 | -$20,311 |
| Stock-Based Comp. | $13,533 | $3,810 | $9,026 | $1,281 |
| Change in WC | -$9,763 | -$5,946 | $668 | -$7,389 |
| Other Non-Cash | -$47,876 | -$44,315 | $17,211 | -$1,052 |
| Operating Cash Flow | -$113,895 | -$109,043 | -$67,894 | -$36,596 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,470 | -$4,628 | -$3,900 | -$281 |
| Net Acquisitions | $0 | -$1,350 | $0 | $0 |
| Inv. Purchases | -$66,035 | -$8,014 | -$16,025 | -$195,132 |
| Inv. Sales/Matur. | $60,048 | $16,525 | $79,600 | $154,850 |
| Other Inv. Act. | $0 | $350 | -$750 | $0 |
| Investing Cash Flow | -$9,457 | $2,883 | $58,925 | -$40,563 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,795 | $2,053 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$31,980 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,155 | $164,077 | $91,703 | $12,656 |
| Financing Cash Flow | $2,155 | $164,077 | $91,703 | $12,656 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$121,197 | $57,917 | $82,734 | -$64,503 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $169,978 | $112,061 | $29,327 | $93,829 |
| End Cash | $48,781 | $169,978 | $112,061 | $29,326 |
| Free Cash Flow | -$117,365 | -$113,671 | -$71,794 | -$36,877 |